A MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting
Silvia Pomella(University of Rome Tor Vergata), Rossella Rota(Bambino Gesù Children's Hospital)
Cited by 1
Related Papers
MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma
|Clinical Epigenetics|2015|41
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting
|Nature Communications|2023|21